Dolby Laboratories Cash Flow Statement
NYSE: DLBMiscellaneousMulti-Sector CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dolby Laboratories free cash flow
In fiscal 2025, Dolby Laboratories generated $472.2 million of operating cash flow and spent $36.3 million on capital expenditures. That left free cash flow of $435.9 million, a free-cash-flow margin of 32.3% of revenue. Free cash flow was up 46.6% from the prior year's $297.2 million.
Dolby Laboratories returned $251.6 million to shareholders: $126.6 million in dividends and $125.0 million in share repurchases, equal to 58% of free cash flow. Free cash flow covered dividend payments 3.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
Dolby Laboratories cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-09-26 | FY 20242024-09-27 | FY 20232023-09-29 | FY 20222022-09-30 | FY 20212021-09-24 | FY 20202020-09-25 | FY 20192019-09-27 | FY 20182018-09-28 | FY 20172017-09-29 | FY 20162016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 256.49M | 264.32M | 201.64M | 183.90M | 317.82M | 231.62M | 255.50M | 42.30M | 207.11M | 186.40M |
| Net Income growth (YoY) | -2.96% | +31.08% | +9.65% | -42.14% | +37.22% | -9.35% | +503.96% | -79.57% | +11.11% | +1.73% |
| Depreciation & Amortization | 87.83M | 75.56M | 82.56M | 88.46M | 95.86M | 90.88M | 85.12M | 81.28M | 84.31M | 85.15M |
| Stock-Based Compensation | 128.51M | 119.83M | 118.49M | 114.92M | 99.70M | 86.63M | 76.58M | 71.25M | 65.34M | 66.98M |
| Change in Working Capital | 22.55M | -77.93M | -27.36M | -51.27M | 31.88M | -64.38M | -15.29M | 11.96M | 27.70M | 19.84M |
| Operating Cash Flow | 472.20M | 327.25M | 367.08M | 318.58M | 447.75M | 343.85M | 327.67M | 352.20M | 377.79M | 360.06M |
| Capital Expenditures | -36.35M | -30.01M | -30.34M | -47.93M | -54.45M | -66.35M | -96.28M | -72.81M | -99.62M | -100.76M |
| Investing Cash Flow | -10.59M | -286.29M | 54.21M | -295.94M | -44.91M | 134.37M | -56.23M | 78.09M | -158.03M | -282.50M |
| Dividends Paid | -126.60M | -114.58M | -103.41M | -100.07M | -89.17M | -88.58M | -77.50M | -66.16M | -57.06M | -48.40M |
| Share Repurchases | -124.99M | -160.00M | -149.28M | -530.49M | -245.86M | -173.74M | -340.58M | -150.47M | -100.00M | -100.85M |
| Financing Cash Flow | -247.24M | -287.81M | -236.81M | -610.56M | -252.51M | -207.78M | -385.28M | -133.63M | -106.83M | -91.99M |
| Net Change in Cash | 215.61M | -240.21M | 189.59M | -604.66M | 153.05M | 274.39M | -119.66M | 290.88M | 110.91M | -15.81M |
| Free Cash Flow | 435.85M | 297.25M | 336.74M | 270.65M | 393.30M | 277.50M | 231.39M | 279.39M | 278.18M | 259.30M |
This table shows 10 annual periods of Dolby Laboratories's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DLB's reporting calendar. What is a cash flow statement?